Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells

Journal of Experimental Medicine

Volumn 213, Issue 6, 2016, Pages 921-928

  Kalchschmidt, Jens S ^a   Bashford Rogers, Rachael ^b,c   Paschos, Kostas ^a   Gillman, Adam C T ^a   Styles, Christine T ^a   Kellam, Paul ^b   Allday, Martin J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 3C; UNCLASSIFIED DRUG; AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); CYTIDINE DEAMINASE; EBNA-3C, EPSTEIN-BARR VIRUS; TUMOR PROTEIN;

ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL; SOMATIC MUTATION; TRANSACTIVATION; TRANSCRIPTION INITIATION SITE; BURKITT LYMPHOMA; CELL LINE; DNA RESPONSIVE ELEMENT; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENETICS; HUMAN; IMMUNOLOGY; MALE; SOMATIC HYPERMUTATION;

BURKITT LYMPHOMA; CELL LINE; CYTIDINE DEAMINASE; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT, B-LYMPHOCYTE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; NEOPLASM PROTEINS; RESPONSE ELEMENTS; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 84971523931     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20160120     Document Type: Article

References (31)

1. Allday, M.J. 2009. How does Epstein-Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma? Semin. Cancer Biol. 19:366-376. http://dx.doi.org/10.1016/j.semcancer.2009.07.007
2. Allday, M.J., Q. Bazot, and R.E. White. 2015. The EBNA3 family: two oncoproteins and a tumour suppressor that are central to the biology of EBV in B cells. Curr. Top. Microbiol. Immunol. 391:61-117. http://dx.doi.org/10.1007/978-3-319-22834-1_3
3. Altschul, S.F., W. Gish, W. Miller, E.W. Myers, and D.J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410. http://dx.doi.org/10.1016/S0022-2836(05)80360-2
4. Anderton, E., J. Yee, P. Smith, T. Crook, R.E. White, and M.J. Allday. 2008. Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene. 27:421-433. http://dx.doi.org/10.1038/sj.onc.1210668
5. Bashford-Rogers, R.J.M., A.L. Palser, B.J. Huntly, R. Rance, G.S. Vassiliou, G.A. Follows, and P. Kellam. 2013. Network properties derived from deep sequencing of human B-cell receptor repertoires delineate B-cell populations. Genome Res. 23:1874-1884. http://dx.doi.org/10.1101/gr.154815.113
6. Calderwood, M.A., S. Lee, A.M. Holthaus, S.C. Blacklow, E. Kieff, and E. Johannsen. 2011. Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth. Virology. 414:19-25. http://dx.doi.org/10.1016/j.virol.2011.02.018
7. Epeldegui, M., Y.P. Hung, A. McQuay, R.F. Ambinder, and O. Martínez-Maza. 2007. Infection of human B cells with Epstein-Barr virus results in the expression of somatic hypermutation-inducing molecules and in the accrual of oncogene mutations. Mol. Immunol. 44:934-942. http://dx.doi.org/10.1016/j.molimm.2006.03.018
8. Gil, Y., S. Levy-Nabot, M. Steinitz, and R. Laskov. 2007. Somatic mutations and activation-induced cytidine deaminase (AID) expression in established rheumatoid factor-producing lymphoblastoid cell line. Mol. Immunol. 44:494-505. http://dx.doi.org/10.1016/j.molimm.2006.02.012
9. He, B., N. Raab-Traub, P. Casali, and A. Cerutti. 2003. EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APR IL to induce T cell-independent Ig heavy chain class switching. J. Immunol. 171:5215-5224. http://dx.doi.org/10.4049/jimmunol.171.10.5215
10. Heath, E., N. Begue-Pastor, S. Chaganti, D. Croom-Carter, C. Shannon-Lowe, D. Kube, R. Feederle, H.-J. Delecluse, A.B. Rickinson, and A.I. Bell. 2012. Epstein-Barr virus infection of naïve B cells in vitro frequently selects clones with mutated immunoglobulin genotypes: implications for virus biology. PLoS Pathog. 8:e1002697. http://dx.doi.org/10.1371/journal.ppat.1002697
11. Hwang, J.K., F.W. Alt, and L.-S. Yeap. 2015. Related mechanisms of antibody somatic hypermutation and class switch recombination. Microbiol. Spectr. 3:MDNA3-0037-2014. http://dx.doi.org/10.1128/microbiolspec.MDNA3-0037-2014
12. Kalchschmidt, J.S., A.C.T. Gillman, K. Paschos, Q. Bazot, B. Kempkes, and M.J. Allday. 2016. EBNA3C directs recruitment of RBPJ (CBF1) to chromatin during the process of gene repression in EBV infected B cells. PLoS Pathog. 12:e1005383. http://dx.doi.org/10.1371/journal.ppat.1005383
13. Kieffer-Kwon, K.-R., Z. Tang, E. Mathe, J. Qian, M.-H. Sung, G. Li, W. Resch, S. Baek, N. Pruett, L. Grøntved, et al. 2013. Interactome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation. Cell. 155:1507-1520. http://dx.doi.org/10.1016/j.cell.2013.11.039
14. Lefranc, M.-P., V. Giudicelli, C. Ginestoux, J. Jabado-Michaloud, G. Folch, F. Bellahcene, Y. Wu, E. Gemrot, X. Brochet, J. Lane, et al. 2009. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 37:D1006-D1012. http://dx.doi.org/10.1093/nar/gkn838
15. Qian, J., Q. Wang, M. Dose, N. Pruett, K.-R. Kieffer-Kwon, W. Resch, G. Liang, Z. Tang, E. Mathé, C. Benner, et al. 2014. B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell. 159:1524-1537. http://dx.doi.org/10.1016/j.cell.2014.11.013
16. Rao, S.S.P., M.H. Huntley, N.C. Durand, E.K. Stamenova, I.D. Bochkov, J.T. Robinson, A.L. Sanborn, I. Machol, A.D. Omer, E.S. Lander, and E.L. Aiden. 2014. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 159:1665-1680. http://dx.doi.org/10.1016/j.cell.2014.11.021
17. Robbiani, D.F., and M.C. Nussenzweig. 2013. Chromosome translocation, B cell lymphoma, and activation-induced cytidine deaminase. Annu. Rev. Pathol. 8:79-103. http://dx.doi.org/10.1146/annurev-pathol-020712-164004
18. Robbiani, D.F., S. Deroubaix, N. Feldhahn, T.Y. Oliveira, E. Callen, Q. Wang, M. Jankovic, I.T. Silva, P.C. Rommel, D. Bosque, et al. 2015. Plasmodium infection promotes genomic instability and AID-dependent B cell lymphoma. Cell. 162:727-737. http://dx.doi.org/10.1016/j.cell.2015.07.019
19. Rowe, M., G.L. Kelly, A.I. Bell, and A.B. Rickinson. 2009. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Semin. Cancer Biol. 19:377-388. http://dx.doi.org/10.1016/j.semcancer.2009.07.004
20. Schmitz, R., M. Ceribelli, S. Pittaluga, G. Wright, and L.M. Staudt. 2014. Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harb. Perspect. Med. 4:a014282. http://dx.doi.org/10.1101/cshperspect.a014282
21. INK4a is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines. PLoS Pathog. 9:e1003187. http://dx.doi.org/10.1371/journal.ppat.1003187
22. Skalsky, R.L., and B.R. Cullen. 2015. EBV noncoding RNAs. Curr. Top. Microbiol. Immunol. 391:181-217. http://dx.doi.org/10.1007/978-3-319-22834-1_6
23. Subramanian, C., S. Hasan, M. Rowe, M. Hottiger, R. Orre, and E.S. Robertson. 2002. Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation. J. Virol. 76:4699-4708. http://dx.doi.org/10.1128/JVI.76.10.4699-4708.2002
24. Thorley-Lawson, D.A. 2015. EBV persistence-introducing the virus. Curr. Top. Microbiol. Immunol. 390:151-209. http://dx.doi.org/10.1007/978-3-319-22822-8_8
25. Thorley-Lawson, D.A., and M.J. Allday. 2008. The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat. Rev. Microbiol. 6:913-924. http://dx.doi.org/10.1038/nrmicro2015
26. Tobollik, S., L. Meyer, M. Buettner, S. Klemmer, B. Kempkes, E. Kremmer, G. Niedobitek, and B. Jungnickel. 2006. Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth. Blood. 108:3859-3864. http://dx.doi.org/10.1182/blood-2006-05-021303
27. Torgbor, C., P. Awuah, K. Deitsch, P. Kalantari, K.A. Duca, and D.A. Thorley-Lawson. 2014. A multifactorial role for P. falciparum malaria in endemic Burkitt's lymphoma pathogenesis. PLoS Pathog. 10:e1004170. http://dx.doi.org/10.1371/journal.ppat.1004170
28. Wang, H., C. Zang, L. Taing, K.L. Arnett, Y.J. Wong, W.S. Pear, S.C. Blacklow, X.S. Liu, and J.C. Aster. 2014. NOT CH1-RBPJ complexes drive target gene expression through dynamic interactions with superenhancers. Proc. Natl. Acad. Sci. USA. 111:705-710. http://dx.doi.org/10.1073/pnas.1315023111
29. Watson, S.J., M.R.A. Welkers, D.P. Depledge, E. Coulter, J.M. Breuer, M.D. de Jong, and P. Kellam. 2013. Viral population analysis and minority-variant detection using short read next-generation sequencing. Philos. Trans. R. Soc. Lond. B Biol. Sci. 368:20120205. http://dx.doi.org/10.1098/rstb.2012.0205
30. Young, L.S., and A.B. Rickinson. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer. 4:757-768. http://dx.doi.org/10.1038/nrc1452
31. Zan, H., and P. Casali. 2013. Regulation of Aicda expression and AID activity. Autoimmunity. 46:83-101. http://dx.doi.org/10.3109/08916934.2012.749244